FDA Import Refusal 1FX-2009898-5/10002/1 — ASTRAZENECA PHARMA INDIA LTD
The FDA refused shipment 1FX-2009898-5/10002/1 from ASTRAZENECA PHARMA INDIA LTD (India) on Sep 8, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 8, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,75